Moreover, as elevated hepatic p53 correlates with hyperglycemia and HOMA-IR in T2DM patients and impairs insulin sensitivity (45), we observed that CUR treatment markedly reduced T2DM-induced p53 phosphorylation. The gene discussed is INS; the disease is type 2 diabetes mellitus.